Bill Text: NY S03467 | 2023-2024 | General Assembly | Amended

New York Senate Bill 3467

Bill Title: Allows a licensed pharmacist to order and administer certain tests.

Spectrum: Slight Partisan Bill (Democrat 10-5)

Status: (Introduced) 2024-01-24 - ADVANCED TO THIRD READING [S03467 Detail]

Download: New_York-2023-S03467-Amended.html


                STATE OF NEW YORK
        ________________________________________________________________________

                                         3467--A

                               2023-2024 Regular Sessions

                    IN SENATE

                                    January 31, 2023
                                       ___________

        Introduced  by  Sens.  RIVERA,  ADDABBO,  GALLIVAN,  GOUNARDES, KRUEGER,
          SKOUFIS -- read twice and ordered printed,  and  when  printed  to  be
          committed  to  the  Committee  on Health -- committee discharged, bill
          amended, ordered reprinted as amended and recommitted to said  commit-
          tee

        AN  ACT  to  amend the education law, in relation to allowing a licensed
          pharmacist to order and administer certain tests; and to amend part  C
          of  chapter  57 of the laws of 2022 amending the public health law and
          the education law relating to allowing pharmacists to  direct  limited
          service  laboratories  and order and administer COVID-19 and influenza
          tests and modernizing nurse practitioners, in relation to  the  effec-
          tiveness thereof

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 7 of section 6801  of  the  education  law,  as
     2  added  by  section  2  of  part  C of chapter 57 of the laws of 2022, is
     3  amended to read as follows:
     4    7. A licensed pharmacist is a qualified health care professional under
     5  section five hundred seventy-one  of  the  public  health  law  for  the
     6  purposes  of  directing  a  limited  service laboratory and ordering and
     7  administering COVID-19 [and],  influenza,  respiratory  syncytial  virus
     8  (RSV),  pharyngitis  resulting  from  a Group A streptococcal infection,
     9  HbA1c, hepatitis C, and human immunodeficiency virus (HIV) tests author-
    10  ized by the Food and Drug Administration (FDA), subject  to  certificate
    11  of  waiver  requirements  established  pursuant  to the federal clinical
    12  laboratory improvement act of nineteen hundred eighty-eight.
    13    § 2. Section 8 of part C of chapter 57 of the laws  of  2022  amending
    14  the public health law and the education law relating to allowing pharma-
    15  cists  to  direct  limited service laboratories and order and administer
    16  COVID-19 and influenza tests and  modernizing  nurse  practitioners,  is
    17  amended to read as follows:

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD02558-07-3

        S. 3467--A                          2

     1    §  8.  This  act  shall take effect immediately and shall be deemed to
     2  have been in full force and effect on and after April 1, 2022; provided,
     3  however, that sections one, two, three, four, six and seven of this  act
     4  shall expire and be deemed repealed [two] four years after it shall have
     5  become a law.
     6    §  3.  This act shall take effect immediately; provided, however, that
     7  the amendments to subdivision 7 of section 6801  of  the  education  law
     8  made  by  section  one  of  this act shall not affect the repeal of such
     9  subdivision and shall be deemed repealed therewith.